As leading drugmakers hint to shareholders that Medicare's final price offers may not impact long-term sales, several prominent drug price control advocacy groups are gathering tens of thousands of signatures for a petition demanding drug makers withdraw their lawsuits against Medicare drug price negotiations. Patients for Affordable Drugs (P4AD), Public Citizen, Social Security Works and other price control advocates so far have collected 189,0006 for a petition urging pharmaceutical CEOs to drop their lawsuits. Once the petition reaches 200,000 signatures...